Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2000;53:581-586; doi:10.1136/jcp.53.8.581
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol 2000; 53:581-586
© 2000 Journal of Clinical Pathology

Leader

HTLV-1 infections

Charles R M Bangham1

1 Department of Immunology, Imperial College School of Medicine, St Mary's Campus, London W2 1PG, UK

Correspondence to:
Professor Bangham email: c.bangham{at}ic.ac.uk

Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of these diseases, and is beginning to explain why some HTLV-1 infected people develop serious illnesses whereas most remain healthy life long carriers of the virus. These findings might be applicable to other persistent virus infections such as human immunodeficiency virus, hepatitis B, and hepatitis C.

Key Words: human T lymphotropic virus type 1 • adult T cell leukaemia/lymphoma • tropical spastic paraparesis • myelopathy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Mitchell, M. S., Bodine, E. T., Hill, S., Princler, G., Lloyd, P., Mitsuya, H., Matsuoka, M., Derse, D. (2007). Phenotypic and Genotypic Comparisons of Human T-Cell Leukemia Virus Type 1 Reverse Transcriptases from Infected T-Cell Lines and Patient Samples. J. Virol. 81: 4422-4428 [Abstract] [Full Text]  
  • Agnellini, P., Wolint, P., Rehr, M., Cahenzli, J., Karrer, U., Oxenius, A. (2007). Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. USA 104: 4565-4570 [Abstract] [Full Text]  
  • Plancoulaine, S., Gessain, A., Tortevoye, P., Boland-Auge, A., Vasilescu, A., Matsuda, F., Abel, L. (2006). A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27. Hum Mol Genet 15: 3306-3312 [Abstract] [Full Text]  
  • Mitra-Kaushik, S., Harding, J., Hess, J., Schreiber, R., Ratner, L. (2004). Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma. Blood 104: 3305-3311 [Abstract] [Full Text]  
  • Mitra-Kaushik, S., Harding, J. C., Hess, J. L., Ratner, L. (2004). Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood 104: 802-809 [Abstract] [Full Text]  
  • Dodon, M. D., Li, Z., Hamaia, S., Gazzolo, L. (2004). Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells. J. Gen. Virol. 85: 1921-1932 [Abstract] [Full Text]  
  • Chung, H.-K., Young, H. A., Goon, P. K. C., Heidecker, G., Princler, G. L., Shimozato, O., Taylor, G. P., Bangham, C. R. M., Derse, D. (2003). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 102: 4130-4136 [Abstract] [Full Text]  
  • Ding, W., Kim, S.-J., Nair, A. M., Michael, B., Boris-Lawrie, K., Tripp, A., Feuer, G., Lairmore, M. D. (2003). Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation. J. Virol. 77: 11027-11039 [Abstract] [Full Text]  
  • Imirizaldu, J J Z., Esteban, J C G., Axpe, I R., Concha, T P., Juanes, F V., Susaeta, I A., Carranceja, J M C. (2003). Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J. Neurol. Neurosurg. Psychiatry 74: 1080-1084 [Abstract] [Full Text]  
  • Ding, W., Albrecht, B., Kelley, R. E., Muthusamy, N., Kim, S.-J., Altschuld, R. A., Lairmore, M. D. (2002). Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells. J. Virol. 76: 10374-10382 [Abstract] [Full Text]  
  • Albrecht, B., Lairmore, M. D. (2002). Critical Role of Human T-Lymphotropic Virus Type 1 Accessory Proteins in Viral Replication and Pathogenesis. Microbiol. Mol. Biol. Rev. 66: 396-406 [Abstract] [Full Text]  
  • Debacq, C., Asquith, B., Kerkhofs, P., Portetelle, D., Burny, A., Kettmann, R., Willems, L. (2002). Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA 99: 10048-10053 [Abstract] [Full Text]  
  • Albrecht, B., D'Souza, C. D., Ding, W., Tridandapani, S., Coggeshall, K. M., Lairmore, M. D. (2002). Activation of Nuclear Factor of Activated T Cells by Human T-Lymphotropic Virus Type 1 Accessory Protein p12I. J. Virol. 76: 3493-3501 [Abstract] [Full Text]  
  • Lomas, M., Hanon, E., Tanaka, Y., Bangham, C. R. M., Gould, K. G. (2002). Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin. J. Gen. Virol. 83: 641-650 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs